Comments
FDA rejects Watson/Columbia premature birth drug
28.02.2012. | (Reuters) - U.S. health regulators have rejected a vaginal gel from Watson Pharmaceuticals and Columbia Laboratories aimed at reducing the risk of premature birth, the companies said on Monday....
